A Major Cochrane Review Casts Doubt on the Efficacy and Safety of Amyloid-Targeting Alzheimer’s Drugs
A comprehensive analysis of 17 clinical trials involving over 20,000 participants has concluded that drugs designed to target amyloid beta proteins in the brain are unlikely to offer significant clinical…







